National Standard for User-applied Labelling of Injectable Medicines,

National Standard for User-applied Labelling of Injectable Medicines,

National Standard for User-applied Labelling of Injectable Medicines, Fluids and Lines June 2016 Presentation summary Labelling for safety Labelling Standard Aims Minimum requirements Outline and content Application in clinical practice

National Standard for User-applied Labelling of Injectable Medicines, Fluids and Lines 2 Labelling for safety Labelling of injectable medicines, fluids and delivery devices is a major patient safety issue Medicines removed from original manufacturers packaging must be identifiable Incomplete/omitted labelling is a source of medication error National Standard for User-applied Labelling of Injectable Medicines, Fluids and Lines

3 Medicine administration errors Errors relating to absent or inadequate labelling include: Wrong medicine Wrong route Wrong patient Errors attributable to labelling have been associated with: Patient transfer Perioperative sterile field 0.9% sodium chloride flush Line misconnections National Standard for User-applied Labelling of Injectable Medicines, Fluids and Lines

4 Medicine administration errors: case reports 10 mg morphine was given in error as the clinician thought the syringe contained 0.9% sodium chloride. The unlabelled syringe had a 0.9% sodium chloride ampoule attached (unpublished) A patient was given intravenous (IV) lignocaine with adrenaline solution intended for local anaesthetic infiltration. This syringe had been drawn up and placed in a kidney dish alongside IV morphine and midazolam for procedural sedation (unpublished) National Standard for User-applied Labelling of Injectable Medicines, Fluids and Lines

5 The Labelling Standard National Standard for Userapplied Labelling of Injectable Medicines, Fluids and Lines, September 2015 Replaces the previous Labelling Recommendations (2012) and Issues Register National Standard for User-applied Labelling of Injectable Medicines, Fluids and Lines 6 The Labelling Standard A national standard for

clinical practice in Australia Identifies medicines and fluids removed from original manufacturers packaging prior to patient administration Identifies line route National Standard for User-applied Labelling of Injectable Medicines, Fluids and Lines 7 Labelling Standard aims Provide standardisation for user-applied labelling of injectable medicines Provide minimum requirements for userapplied labelling of injectable medicines

Promote safer use of injectable medicines National Standard for User-applied Labelling of Injectable Medicines, Fluids and Lines 8 Labelling Standard development Draft recommendations developed by NSW Therapeutic Advisory Group Safer Medicines Group National consultation and pilot testing supported by the Australian Commission on Safety and Quality in Health Care commenced in 2009 Labelling Recommendations endorsed by Australian Health Ministers in November 2010 Further evaluation, particularly in perioperative areas and interventional procedure rooms

Labelling Standard published September 2015 National Standard for User-applied Labelling of Injectable Medicines, Fluids and Lines 9 Labelling Standard development Based on: International literature/recommendations Australian Standard AS4940: 2002 Userapplied identification labels for use on fluid bags, syringes and drug administration lines Expert opinion and consultation Pilot testing Reported medicine administration incidents National Standard for User-applied Labelling of Injectable Medicines, Fluids and Lines

10 Labelling Standard consultation Labelling Standard development since 2009 has involved: Cardiac Society of Australia and New Zealand State and territory safer medicines groups Catheter Laboratory Nursing Council

Australian Association of Nuclear Medicine Specialists Clinical Oncological Society of Australia College of Emergency Nursing Australia

Australian College of Critical Care Nurses Consumers Health Forum Australian College of Nursing Council of Australian Therapeutic Advisory Groups

Australian College of Operating Room Nurses Australian and New Zealand College of Anaesthetists Intensive Care Coordination and Monitoring Unit, New South Wales Renal Society of Australasia

Australian and New Zealand Intensive Care Society Australian and New Zealand Society for Nuclear Medicine Royal Australian and New Zealand College of Radiologists

Australian Nursing and Midwifery Federation SESIAHS Sterilising Services, Randwick Hospitals Campus Australian Pharmaceutical Healthcare Systems Society of Hospital Pharmacists of Australia

Australian Private Hospitals Association Womens & Childrens Hospitals Australasia Cancer Council Australia State and territory health departments

National Standard for User-applied Labelling of Injectable Medicines, Fluids and Lines 11 Labelling Standard: minimum requirements Medicines or fluid removed from original packaging must be identifiable All containers (e.g. bags and syringes) containing medicines must be labelled on leaving the hands of the person preparing the medicine Prepare and label one medicine at a time Discard medicines or fluids in unlabelled containers National Standard for User-applied Labelling of

Injectable Medicines, Fluids and Lines 12 Labelling Standard: outline What should be labelled What should be included on the label Where the label should be placed National Standard for User-applied Labelling of Injectable Medicines, Fluids and Lines 13

Labelling Standard: scope National Standard for User-applied Labelling of Injectable Medicines, Fluids and Lines 14 Labelling Standard: exclusions Injectable medicines and fluids: prepared by hospital pharmacy departments, external manufacturers or compounding centres not directly administered to the patient (e.g. ampoules) Administration portals

Syringe drivers and pumps National Standard for User-applied Labelling of Injectable Medicines, Fluids and Lines 15 Application in clinical practice National Standard for User-applied Labelling of Injectable Medicines, Fluids and Lines 16 All containers: label content Patient: Given name and family name Identifier (ID): This is the URN or MRN or other

local unique patient identifier DOB: Patients date of birth For each medicine added to the container, specify: Generic medicine name Amount (total added to the container) including units Volume (the total volume of fluid in the container) in mL Concentration (units/mL) Diluent (syringes only) Date and time of preparation Signed by personnel preparing and checking medicine National Standard for User-applied Labelling of Injectable Medicines, Fluids and Lines 17

All containers: label content Example of miscellaneous route syringe label Example of subcutaneous route syringe label National Standard for User-applied Labelling of Injectable Medicines, Fluids and Lines 18 Identifying target tissue/ route of administration A standard colour system is used to identify the

target tissue/intended route of administration* Target tissue Route of administration Colour Intra-arterial Intra-arterial Red Intravenous Intravenous

Blue Neural Epidural / Intrathecal / Regional Yellow Subcutaneous Subcutaneous Beige Intragastric

Enteral Green Respiratory Inhalational White Miscellaneous Any other route not specified above Pink

*Modified from Australian Standard AS4940 National Standard for User-applied Labelling of Injectable Medicines, Fluids and Lines 19 Bag and syringe labels: 2 sizes National Standard for User-applied Labelling of Injectable Medicines, Fluids and Lines 20 Bags with additives Bags (and bottles) require labelling when a

medicine is added in the clinical/ward area Label IMMEDIATELY when an injectable medicine is added The diluent should be identified on the label if the base fluid is not easily identifiable from the original manufacturers label (see label placement) National Standard for User-applied Labelling of Injectable Medicines, Fluids and Lines 21 Bags with additives (continued) Placement:

Place labels on the FRONT of the bag to ensure the name of base fluid, batch number and expiry date remain visible Place slightly off centre to ensure graduations on one side of the bag remain visible National Standard for User-applied Labelling of Injectable Medicines, Fluids and Lines 22

Syringes for bolus or infusion Label IMMEDIATELY all injectable medicines drawn up in syringes that leave the hand of the operator Prepare and label multiple syringes sequentially in independent operations Exception: Labelling is not required when preparation and bolus administration of a SINGLE medicine from a SINGLE syringe are one uninterrupted process, and the syringe DOES NOT leave the hands of the person who prepared it, and the same person administers the medicine IMMEDIATELY National Standard for User-applied Labelling of Injectable Medicines, Fluids and Lines 23

Syringes for bolus or infusion (continued) Placement Place label so graduations on the syringe scale remain visible Apply parallel to the long axis of the syringe barrel, top edge flush with scale Apply label as a flag for small syringes National Standard for User-applied Labelling of Injectable Medicines, Fluids and Lines 24 Labelling IV flushes Label any fluid drawn up in a syringe for

use as an IV flush (e.g. 0.9% sodium chloride) unless preparation and bolus administration is one uninterrupted process. National Standard for User-applied Labelling of Injectable Medicines, Fluids and Lines 25 All containers: discarding content Any unlabelled container holding a solution must be immediately discarded Any container, where there is doubt over content, must be discarded Any medicine remaining in the container at the end of a procedure must be discarded

National Standard for User-applied Labelling of Injectable Medicines, Fluids and Lines 26 Lines and catheters: route of administration National Standard for User-applied Labelling of Injectable Medicines, Fluids and Lines 27 Lines and catheters: route of administration (continued)

Labelling administration lines and catheters Label all lines to identify route Add date and time the line was commenced Identify catheters where there is a risk of wrong route administration (e.g. where the patient entry portal is distant from the administration site) Labelling invasive monitoring lines Identify all lines, including those not primarily intended for medicine administration National Standard for User-applied Labelling of Injectable Medicines, Fluids and Lines 28 Lines: active ingredient

Identify the active ingredient in administration lines for dedicated continuous infusions. Labels may be preprinted. Colour should comply with ISO26825:2008. For example The pre-printed medicine line label guide has more examples Lines for intermittent infusions may be labelled for medicine content, but ensure label is removed on completion of infusion National Standard for User-applied Labelling of Injectable Medicines, Fluids and Lines 29 Pre-printed medicine line label guide

National Standard for User-applied Labelling of Injectable Medicines, Fluids and Lines 30 Lines Label placement Route: Use colour coded route label Label near the injection port on the patient side* *Exception where there is a possibility of tampering (e.g. paediatric patients) National Standard for User-applied Labelling of

Injectable Medicines, Fluids and Lines 31 Lines (continued) Label placement Active ingredient: Use medicine line label (preprinted where possible) Label adjacent to route label Label close to patient entry portal* *Exception where there is a possibility of tampering (e.g. paediatric patients) National Standard for User-applied Labelling of Injectable Medicines, Fluids and Lines

32 Catheter lock For central venous access devices that are locked with a medicine (e.g. heparin) Label to partially cover the catheter dressing Remove label after removing medicine from the lock ADD PHOTOGRAPH National Standard for User-applied Labelling of Injectable Medicines, Fluids and Lines

33 Burettes Use peel-off labels reserved for use on burettes ONLY Place label so that text is upright and ensure that the burette graduations are not obscured Burette labels must be removed once the medicine has been administered to the patient National Standard for User-applied Labelling of Injectable Medicines, Fluids and Lines 34

Non-injectable medicines: enteral route Syringe and line labels Syringes for noninjectable solutions must not be compatible with parenteral entry points National Standard for User-applied Labelling of Injectable Medicines, Fluids and Lines 35

Non-injectable medicines: inhalation route Label syringes used to measure nebuliser solutions National Standard for User-applied Labelling of Injectable Medicines, Fluids and Lines 36 Closed-practice environments National Standard for User-applied Labelling of Injectable Medicines, Fluids and Lines

37 Sterile field (i.e. aseptic conditions) Closed-practice environment: where patient identification is established and other means of recording labelling and preparation signatories are available Examples: perioperative sterile field, interventional cardiology and radiology procedure rooms National Standard for User-applied Labelling of Injectable Medicines, Fluids and Lines 38 Sterile field (continued)

Any container holding medicines or fluids on the perioperative sterile field must be identifiable Preprinted abbreviated container labels can be used Non-injectable medicines and fluids are identified with a red St Andrews Cross watermark Sterile markers must be available to complete generic labels National Standard for User-applied Labelling of Injectable Medicines, Fluids and Lines 39 Perioperative environments

National Standard for User-applied Labelling of Injectable Medicines, Fluids and Lines 40 Perioperative environments Continue to label syringes containing drugs used during anaesthesia to comply with ISO26825:2008 Use preprinted labels or the peel off abbreviated container label where patient identity is established and there are other means of recording labelling and preparation signatories

National Standard for User-applied Labelling of Injectable Medicines, Fluids and Lines 41 Perioperative environments National Standard for User-applied Labelling of Injectable Medicines, Fluids and Lines 42 Perioperative sterile field Use preprinted label sheets with medicine name and concentration. Colour coding to follow ISO26825:2008 (Anaesthetic Labelling Standard)

Use abbreviated container label where preprinted labels unavailable Labels must remain intact for duration of procedure Labels must adhere for duration of procedure Labels should be removed at the end of the procedure for reusable hollowware containers National Standard for User-applied Labelling of Injectable Medicines, Fluids and Lines 43 Perioperative sterile field Example of preprinted label sheet for perioperative

sterile field Note that labels for non-injectable fluids (with the St Andrews Cross) are in a separate section on the sheet National Standard for User-applied Labelling of Injectable Medicines, Fluids and Lines 44 Interventional cardiology, radiology and other low-light procedure areas

National Standard for User-applied Labelling of Injectable Medicines, Fluids and Lines 45 Low-light procedure areas Use preprinted label sheets with medicine name Colour coding to follow ISO26825:2008 (Anaesthetic Labelling Standard) Example preprinted label sheet for cardiac catheter laboratory

National Standard for User-applied Labelling of Injectable Medicines, Fluids and Lines 46 Further information: Australian Commission on Safety and Quality in Health Care www.safetyandquality.gov.au National Standard for User-applied Labelling of Injectable Medicines, Fluids and Lines 47

Recently Viewed Presentations

  •  y=sinx,  2 y 0  2  2 3 2

    y=sinx, 2 y 0 2 2 3 2

    Функция y=sinx, её свойства и график y x 1 -1 т 0 0 y x 1 -1 sin = x y т y x 1 -1 y x 1 -1 y x 1 -1 т y x 1 -1 т...
  • Greater copenhagen

    Greater copenhagen

    Greater copenhagen. Northern Europe's hub for science and innovation. Knowledge-intensive. With 14,000 researchers, 160,000 students, 10 university hospitals, 12 universities and 19 science parks & innovation incubators, Greater Copenhagen offers Scandinavia's most knowledge-intensive research and business environment.
  • County Cost Plan Overview August 13, 2015 9:00

    County Cost Plan Overview August 13, 2015 9:00

    National Specialist of Cost Plans. State & Local Governments . Cost Allocation Services. Introductions. Racquel Flanagan. Manager. Fiscal Systems Bureau. Liane Winter. Manager. Fiscal Policy Bureau. Greg Tayros. Accounting Officer. Fiscal Systems Bureau. County Cost Plan Contacts.
  • CSCE 3110 Data Structures & Algorithm Analysis Graphs

    CSCE 3110 Data Structures & Algorithm Analysis Graphs

    A graph G = (V,E) is composed of: V: set of vertices E: set of edges connecting the vertices in V An edge e = (u,v) is a pair of vertices Example: Applications electronic circuits networks (roads, flights, communications) Terminology:...
  • The Research Journal of Kendall Dutcher 2005 2005

    The Research Journal of Kendall Dutcher 2005 2005

    The Research Journal of Kendall Dutcher 2005 - 2007 Primary Mentor: Dr. Douglas F. Barofsky Dept. of Chemistry, Oregon State University, Corvallis, OR 97331
  • Is your graph SALTy?

    Is your graph SALTy?

    Accurate horizontal and vertical scales chosen. The independent variable is shown on the horizontal (across) axis.. The . dependent. variable is shown on the . vertical (up-down) axis.
  • Louisiana Cancer Facts & Figures, All Cancer Sites

    Louisiana Cancer Facts & Figures, All Cancer Sites

    All Cancer Sites. Between 2010 and 2014, the average annual incidence rate#of all cancer sites in Louisiana was the 5th highest and the mortality rate was the 4th highest in the U.S.1
  • Chapter 4

    Chapter 4

    Synectics. Technique used for uncovering perspectives. ... Determine if the idea is a workable solution to the design problem. Construction Kits. Useful strategy. Use construction kits to make a model of the mechanism. Examples: Lego, K'NEX, Meccano, etc.